Axa S.A. Alnylam Pharmaceuticals, Inc. Transaction History

Axa S.A.

$29.5 Billion
Q1 2025

A detailed history of Axa S.A. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Axa S.A. holds 88,652 shares of ALNY stock, worth $38.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

88,652

Previous 95,306 6.98%

Holding current value

$38.6 Million

Previous $22.4 Million 6.74%

% of portfolio

0.08%

Previous 0.07%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$233.07 - $290.7 $1.55 Million - $1.93 Million	-6,654 Reduced 6.98%	88,652 $23.9 Million
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $3.7 Million - $4.78 Million	-15,910 Reduced 14.31%	95,306 $22.4 Million
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $56,348 - $69,169	241 Added 0.22%	111,216 $30.6 Million
Q2 2024 Feb 25, 2025	BUY	$143.31 - $247.0 $2.25 Million - $3.87 Million	15,669 Added 16.44%	110,975 $27 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $478,512 - $824,733	3,339 Added 3.1%	110,975 $27 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $8.71 Million - $11.8 Million	-59,417 Reduced 35.57%	107,636 $16.1 Million
Q4 2023 Jul 16, 2024	BUY	$151.41 - $196.57 $9 Million - $11.7 Million	59,417 Added 55.2%	167,053 $32 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $1.58 Million - $2.05 Million	-10,424 Reduced 5.87%	167,053 $32 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $225,757 - $279,801	-1,322 Reduced 0.74%	177,477 $31.4 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $931,155 - $1.07 Million	5,033 Added 2.9%	178,799 $34 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $5.05 Million - $6.51 Million	-27,650 Reduced 13.73%	173,766 $34.8 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $2.52 Million - $3.28 Million	13,576 Added 7.23%	201,416 $47.9 Million
Q3 2022 Feb 14, 2023	SELL	$138.54 - $232.0 $1.47 Million - $2.46 Million	-10,618 Reduced 5.35%	187,840 $37.6 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $1.47 Million - $2.46 Million	-10,618 Reduced 5.35%	187,840 $37.6 Million
Q2 2022 Feb 14, 2023	SELL	$120.42 - $169.29 $1.14 Million - $1.6 Million	-9,438 Reduced 4.54%	198,458 $28.9 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $1.14 Million - $1.6 Million	-9,438 Reduced 4.54%	198,458 $28.9 Million
Q1 2022 Feb 14, 2023	BUY	$127.18 - $173.91 $2.55 Million - $3.49 Million	20,056 Added 10.68%	207,896 $33.9 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $738,661 - $1.01 Million	-5,808 Reduced 2.72%	207,896 $33.9 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $8.34 Million - $10.9 Million	52,272 Added 32.38%	213,704 $36.2 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $7.2 Million - $8.81 Million	42,426 Added 35.65%	161,432 $30.5 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $5.08 Million - $6.98 Million	-39,466 Reduced 24.9%	119,006 $20.2 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $2.6 Million - $3.6 Million	20,513 Added 14.87%	158,472 $22.4 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $1.07 Million - $1.28 Million	8,741 Added 6.76%	137,959 $17.9 Million
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $515,905 - $704,490	4,257 Added 3.41%	129,218 $18.8 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $553,667 - $831,165	5,313 Added 4.44%	124,961 $18.5 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $1.51 Million - $2.17 Million	-16,167 Reduced 11.9%	119,648 $13 Million
Q4 2019 Feb 18, 2020	SELL	$74.51 - $124.23 $2.28 Million - $3.8 Million	-30,589 Reduced 18.38%	135,815 $15.6 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $25,736 - $31,878	-363 Reduced 0.22%	166,404 $13.4 Million
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $206,668 - $291,175	3,138 Added 1.92%	166,767 $12.1 Million
Q1 2019 May 14, 2019	SELL	$72.76 - $93.45 $19,717 - $25,324	-271 Reduced 0.17%	163,629 $15.3 Million
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $5.63 Million - $7.93 Million	89,821 Added 121.25%	163,900 $12 Million
Q3 2018 Nov 08, 2018	BUY	$87.52 - $122.67 $6.48 Million - $9.09 Million	74,079 New	74,079 $6.48 Million
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $166,376 - $203,095	-1,884 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $218,393 - $279,849	1,884 New	1,884 $225,000
Q4 2017 Feb 13, 2018	SELL	$114.49 - $139.98 $4.62 Million - $5.64 Million	-40,316 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $2.92 Million - $4.77 Million	40,316	40,316 $4.74 Million

Others Institutions Holding ALNY

# of Institutions

746

Shares Held

110M

Call Options Held

966K

Put Options Held

841K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $53.5B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account